Primary tumor and metastasis in ovarian cancer differ in their content of urokinase-type plasminogen activator, its receptor, and inhibitors types 1 and 2.
Year: 1995
Type: article
Study design: Observational Study
Source: PubMed
Institutions: TUM Klinikum, Technical University of Munich
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W1724539534
